tiprankstipranks
Trending News
More News >
Brainhole Technology Limited (HK:2203)
:2203
Hong Kong Market
Advertisement

Brainhole Technology Limited (2203) AI Stock Analysis

Compare
1 Followers

Top Page

HK:2203

Brainhole Technology Limited

(2203)

Rating:41Neutral
Price Target:
HK$0.00
▼(-100.00% Downside)
The overall stock score is primarily driven by significant financial performance issues, including negative profitability margins and deteriorating balance sheet health. Technical analysis offers a mixed but generally weak outlook, while poor valuation further contributes to the low score. The absence of earnings call insights and notable corporate events leaves these components out of consideration.

Brainhole Technology Limited (2203) vs. iShares MSCI Hong Kong ETF (EWH)

Brainhole Technology Limited Business Overview & Revenue Model

Company DescriptionBrainhole Technology Limited (2203) is a company engaged in the technology and electronics sector, specializing in the development and manufacturing of advanced electronic products and solutions. The company focuses on leveraging cutting-edge technology to deliver innovative and efficient solutions catering to a wide range of industries and consumer needs.
How the Company Makes MoneyBrainhole Technology Limited generates revenue through the sale of its advanced electronic products and solutions. The company has established a diversified revenue model that includes direct sales to consumers, partnerships with other companies for product distribution, and potential service agreements for maintenance and support of their technology solutions. Significant factors contributing to its earnings include its ability to innovate and adapt to market demands, strategic partnerships, and its reputation in delivering high-quality products. The company might also engage in licensing agreements or collaborations that provide additional revenue streams.

Brainhole Technology Limited Financial Statement Overview

Summary
Brainhole Technology Limited is struggling financially, with declining revenues, poor profitability, and high leverage. The company's financial health is deteriorating, with significant risks highlighted by negative equity and inconsistent cash flows.
Income Statement
15
Very Negative
The company shows declining revenues and increasing losses over the years. The gross profit margin turned negative in 2024, and the net profit margin is consistently negative, indicating poor profitability. Revenue growth has been negative, with a significant drop in 2024.
Balance Sheet
10
Very Negative
The balance sheet reveals high financial risk with negative stockholders' equity in 2024 and a high debt-to-equity ratio. The equity ratio has declined sharply, indicating increasing leverage and financial instability.
Cash Flow
20
Very Negative
Cash flow statements show inconsistent cash flow generation. Operating cash flow has been negative or negligible in recent years, and free cash flow has been erratic, posing liquidity challenges for the company.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue119.99M220.81M263.57M321.57M261.81M
Gross Profit-6.45M27.63M48.54M54.11M33.52M
EBITDA-88.09M-18.99M-34.46M-19.62M-37.50M
Net Income-127.88M-34.12M-57.61M-51.55M-58.76M
Balance Sheet
Total Assets152.74M279.20M333.42M353.63M370.34M
Cash, Cash Equivalents and Short-Term Investments74.80M111.75M96.73M42.64M74.15M
Total Debt163.71M138.78M147.44M84.93M113.13M
Total Liabilities211.81M212.43M231.84M211.31M183.70M
Stockholders Equity-59.07M66.76M101.58M142.32M186.64M
Cash Flow
Free Cash Flow-39.49M27.21M-113.92M-4.96M-18.72M
Operating Cash Flow-38.96M32.19M-106.08M-535.00K-4.92M
Investing Cash Flow4.23M6.00M11.45M1.48M-55.08M
Financing Cash Flow19.45M-20.10M76.53M-31.00M80.58M

Brainhole Technology Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.19
Price Trends
50DMA
0.19
Positive
100DMA
0.19
Positive
200DMA
0.22
Negative
Market Momentum
MACD
<0.01
Positive
RSI
45.91
Neutral
STOCH
10.71
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2203, the sentiment is Negative. The current price of 0.19 is below the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.19, and below the 200-day MA of 0.22, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 45.91 is Neutral, neither overbought nor oversold. The STOCH value of 10.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2203.

Brainhole Technology Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
HK$66.00M11.003.01%-32.47%-74.03%
64
Neutral
HK$186.00M89.860.60%6.98%
57
Neutral
HK$14.02B9.25-2.83%4.87%9.29%-48.65%
49
Neutral
HK$86.75M-42.18%-6.19%18.71%
48
Neutral
HK$63.17M
27.19%54.51%
45
Neutral
HK$93.83M68.18-21.90%-8.34%-8828.57%
41
Neutral
HK$151.20M-3324.55%-45.66%-275.12%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2203
Brainhole Technology Limited
0.19
0.11
137.50%
HK:1679
Risecomm Group Holdings Limited
0.24
-0.08
-25.00%
HK:1912
Contel Technology Company Limited
0.08
0.00
0.00%
HK:1967
Confidence Intelligence Holdings Limited
0.62
0.34
121.43%
HK:8257
Genes Tech Group Holdings Company Limited
0.07
0.01
16.67%
HK:8490
Niche-Tech Semiconductor Materials Limited
0.13
-0.04
-23.53%

Brainhole Technology Limited Corporate Events

Brainhole Technology Announces Disposal of Beike Shares
Jul 11, 2025

Brainhole Technology Limited has announced the disposal of 147,000 Beike Shares in the open market for approximately HK$7.4 million. This transaction, when combined with previous disposals of Beike ADS, constitutes a discloseable transaction under Hong Kong’s Listing Rules, as the aggregate consideration exceeds 5% but is less than 25% of applicable percentage ratios. This move results in the company holding no remaining Beike Shares or Beike ADS, potentially impacting its investment portfolio and financial strategy.

Brainhole Technology Limited Announces Strategic Securities Transactions
Jul 9, 2025

Brainhole Technology Limited announced the acquisition of 13,600 Robinhood shares and 3,600 Coinbase shares, each for approximately US$1.3 million, and the disposal of 324,000 BigBear shares for approximately US$2.8 million. These transactions, conducted on July 9, 2025, are considered discloseable under Hong Kong’s Listing Rules due to their percentage ratios, impacting the company’s financial positioning and compliance obligations.

Brainhole Technology Limited Strengthens Governance with New Nomination Committee
Jun 13, 2025

Brainhole Technology Limited has established a Nomination Committee to enhance its board governance by identifying and recommending suitable candidates for director positions. The committee, composed mainly of independent non-executive directors, will also oversee board performance evaluations and develop nomination guidelines, thereby reinforcing the company’s commitment to robust corporate governance and strategic leadership.

Brainhole Technology Announces Change in Share Registrar
Jun 13, 2025

Brainhole Technology Limited has announced a change in its Hong Kong Branch Share Registrar and Transfer Office, effective from 14 July 2025. The new registrar will be Union Registrars Limited, and all applications for registration of share transfers will be processed by them from that date. This change is part of the company’s operational adjustments and may impact shareholders who need to collect share certificates.

Brainhole Technology Limited Successfully Passes All AGM Resolutions
May 21, 2025

Brainhole Technology Limited announced that all resolutions proposed at its Annual General Meeting held on May 21, 2025, were passed by shareholders through a poll. The resolutions included the re-election of directors, authorization of director remuneration, reappointment of auditors, and granting of general mandates for share issuance and repurchase. This successful AGM reflects strong shareholder support and positions the company for continued strategic actions and governance alignment.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2025